SKYE
Skye Bioscience, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
No thesis.
Skye Bioscience, Inc.
1.34
+0.03 · +2.27%
post 1.34 −0.08%
No implied move.
No implied move.
Expected move
No implied move.
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | 5AM Venture Management5AM Venture | $6.7M | 59.96% | 0.00% | |
| 2 | Versant Venture ManagementVersant Venture | $1.4M | 12.43% | 0.00% | |
| 3 | Baker Bros. AdvisorsBaker Bros. | $1.1M | 9.76% | 0.00% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $529,370 | 4.73% | −0.08% | |
| 5 | Sphera Funds ManagementSphera Funds | $470,701 | 4.20% | 0.00% | |
| 6 | Platinum Investment ManagementPlatinum | $161,605 | 1.44% | 0.00% | |
| 7 | BlackRockBlackRockindex-like | $161,452 | 1.44% | −18.61% | |
| 8 | Geode Capital ManagementGeodeindex-like | $151,232 | 1.35% | −21.35% | |
| 9 | Millennium ManagementMillennium | $137,637 | 1.23% | −23.11% | |
| 10 | Citadel AdvisorsCitadel | $85,969 | 0.77% | +25.38% | |
| 11 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $72,231 | 0.65% | 0.00% | |
| 12 | State StreetState Streetindex-like | $51,186 | 0.46% | −1.99% | |
| 13 | UBS GroupUBS | $51,143 | 0.46% | +61.27% | |
| 14 | Northern TrustNorthern Trustindex-like | $39,052 | 0.35% | +179.65% | |
| 15 | Qube Research & TechnologiesQube Research & Technologies | $29,869 | 0.27% | new | |
| 16 | Simplex TradingSimplex Trading | $18,702 | 0.17% | new | |
| 17 | XTX TopcoXTX Topco | $14,554 | 0.13% | −48.70% | |
| 18 | Engineers Gate ManagerEngineers Gate Manager | $14,001 | 0.13% | 0.00% | |
| 19 | Group One TradingGroup One Trading | $3,182 | 0.03% | −36.31% | |
| 20 | Vanguard Global AdvisersVanguard Globalindex-like | $3,158 | 0.03% | 0.00% | |
| 21 | Morgan StanleyMorgan Stanley | $1,711 | 0.02% | −3.14% | |
| 22 | BarclaysBarclays | $455 | 0.00% | −96.38% | |
| 23 | Advisor Group HoldingsAdvisor | $413 | 0.00% | 0.00% | |
| 24 | National Bank of CanadaNational Bank of Canada | $275 | 0.00% | 0.00% | |
| 25 | JPMorgan ChaseJPMorgan Chase | $44 | 0.00% | 0.00% |
31 managers report $11.2M of Skye Bioscience on form 13F for the quarter ended Jun 30 '26. 3 of them hold 80% of it; 5AM Venture is largest at 59.96%.